COMMENTARY

Practical AI With Arturo Loaiza-Bonilla: A New Column on AI in Cancer

Arturo Loaiza-Bonilla, MD, MSEd

Disclosures

November 29, 2023

Hello. I'm Dr Arturo Loaiza-Bonilla. Welcome to my inaugural column on Medscape.

At 16, when my journey into medicine began in Colombia, the idea of intertwining artificial intelligence (AI) with healthcare was as outlandish as the plot of a science fiction novel. But today, that "outlandish" idea forms the core of my professional life.

In this column, I aim to demystify AI's role in healthcare and offer you practical yet insightful knowledge, experiences, and strategies to help you navigate this rapidly evolving landscape.

We are collectively part of an extraordinary time where AI is not just a futuristic concept but a present reality altering the way we practice medicine.

Why You Should Read This Column

The world of AI, with its rapidly evolving technologies and complex jargon, can seem overwhelming, but its impact on healthcare — already — is undeniable.

The volume of patient data, our ever-accelerating medical research, and the rising demand for precision medicine all pose significant challenges to healthcare professionals.

They also represent opportunities that can be harnessed by AI. I've had the privilege of experiencing the tremendous potential of AI firsthand as an oncologist, entrepreneur, and cancer researcher.

Whether you're an AI novice or an enthusiast, this column will provide you with a comprehensive and accessible toolkit for using AI in healthcare.

If you have an interest in enhancing your practice, improving patient care, or keeping abreast of cutting-edge medical technology, this column is for you.

What To Expect

In this bi-weekly column, I will be addressing an array of topics revolving around AI in healthcare, with a focus on how you can incorporate AI into your practice, one issue at a time.

While ChatGPT, a powerful AI tool by OpenAI, will be one focus of our discussion, I will also explore various other facets of AI, from early disease detection and personalized care to drug discovery and genomics. As we venture into these topics, I will draw upon my experiences as an oncologist, researcher, and entrepreneur to share advice on how you can integrate these AI advances into your practice.

Thank you for joining me on this journey into the future of healthcare. I look forward to sharing insights, challenging preconceptions, answering your questions, and exploring the transformative power of AI together.

Let's not just adapt to the future of healthcare; let's shape it.

I welcome any questions and topics of interest to make this column even more relevant to other oncologists practicing in the clinic. Contact me at Arturo.AI.MedTech@gmail.com

Arturo Loaiza-Bonilla, MD, MSEd, is the co-founder and chief medical officer at Massive Bio, a company connecting patients to clinical trials using artificial intelligence. His research and professional interests focus on precision medicine, clinical trial design, digital health, entrepreneurship, and patient advocacy. Dr Loaiza-Bonilla serves as medical director of oncology research at Capital Health in New Jersey, where he maintains a connection to patient care by attending to patients 2 days a week.

Follow Medscape on Facebook, X (formerly known as Twitter), Instagram, and YouTube

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.

processing....